Free Account Opening + AMC Free Demat
Loading...

Chemcel Biotech IPO vs Nu Tek India IPO

Comparision between Chemcel Biotech IPO and Nu Tek India IPO.

IPO Details

Chemcel Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Nu Tek India IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Chemcel Biotech IPO Nu Tek India IPO
Logo Chemcel Biotech IPO Logo Nu Tek India IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE BSE, NSE
Lead Managers Allahabad Bank Spa Capital Advisors Ltd
Registrar Bigshare Services Pvt Ltd Aarthi Consultants Pvt Ltd.
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Chemcel Biotech IPO is up to ₹24.64 Cr whereas the issue size of the Nu Tek India IPO is up to ₹86.40 Cr. The final issue price of Chemcel Biotech IPO is ₹16.00 per share and of Nu Tek India IPO is ₹192.00 per share.

  Chemcel Biotech IPO Nu Tek India IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹170.00 per share
Issue Price (Upper) ₹192.00 per share
Issue Price (Final) ₹16.00 per share ₹192.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 30 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 1,54,00,000 shares 45,00,000 shares
Issue Size Total (Amount) up to ₹24.64 Cr up to ₹86.40 Cr

IPO Timetable

Chemcel Biotech IPO opens on Sep 09, 2008, while Nu Tek India IPO opens on Jul 29, 2008. The closing date of Chemcel Biotech IPO and Nu Tek India IPO is Sep 12, 2008, and Aug 01, 2008, respectively.

  Chemcel Biotech IPO Nu Tek India IPO
Anchor Bid Date
Issue Open Sep 09, 2008 Jul 29, 2008
Issue Close Sep 12, 2008 Aug 01, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Chemcel Biotech IPO P/E ratio is , as compared to Nu Tek India IPO P/E ratio of .

  Chemcel Biotech IPO Nu Tek India IPO
Financial
ParticularsFor the year/period ended (Rs. in Lacs)
  30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income61.172347.662180.081223.811337.96
  Profit After Tax (PAT)10.3793.6275.6818.398.41
ParticularsFor the year/period ended (Rs. in Millions)
  30-Sep-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income385.68638.04485.63316.83243.63
  Profit After Tax (PAT)73.69134.2450.8754.6033.26
Promoter Shareholding (Pre-Issue) 57.23% 53.21%
Promoter Shareholding (Post-Issue) 29.4% 42.42%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 9.14%% 23.79%%

Shares Offered

In the Chemcel Biotech IPO retail investors (RII) are offered while in Nu Tek India IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Chemcel Biotech IPO and in Nu Tek India IPO.

  Chemcel Biotech IPO Nu Tek India IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Chemcel Biotech IPO subscribed in total, whereas Nu Tek India IPO subscribed 1.63x.

  Chemcel Biotech IPO Nu Tek India IPO
QIB (times) 2.06x
NII (times) 1.78x
Big NII (times)
Small NII (times)
RII (times) 1.01x
Employee (times) 0.96x
Other (times)
Total (times) 1.63x

Comments

Add a public comment...